Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Drug Resistance

  Free Subscription


16.10.2017

1 Am J Trop Med Hyg
12 Antimicrob Agents Chemother
16 Clin Infect Dis
6 J Antimicrob Chemother
1 J Med Microbiol
2 JAMA
1 PLoS Biol
6 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Trop Med Hyg

  1. SANTOSANINGSIH D, Santoso S, Verbrugh HA, Severin JA, et al
    Risk Factors for Methicillin-Resistant Staphylococcus aureus Carriage among Patients at Admission to the Surgical Ward in a Resource-Limited Hospital in Indonesia.
    Am J Trop Med Hyg. 2017 Sep 18. doi: 10.4269/ajtmh.16-0993.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  2. HUMPHRIES RM, Hindler JA, Wong-Beringer A, Miller SA, et al
    Activity of ceftolozane-tazobactam and ceftazidime-avibactam against beta-lactam resistant Pseudomonas aeruginosa isolates.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01858.
    PubMed     Text format     Abstract available

  3. GIRLICH D, Bonnin RA, Bogaerts P, De Laveleye M, et al
    Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  4. BROWN-ELLIOTT BA, Philley JV, Griffith DE, Thakkar F, et al
    In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  5. HANCOCK SJ, Phan MD, Peters KM, Forde BM, et al
    Identification of IncA/C Plasmid Replication and Maintenance Genes and Development of a Plasmid Multilocus Sequence Typing Scheme.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  6. LEE SJ, Awji EG, Park NH, Park SC, et al
    Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  7. PENROSE KJ, Wallis CL, Brumme CJ, Hamanishi KA, et al
    Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals on Failing First-Line Antiretroviral Therapy in South Africa.
    Antimicrob Agents Chemother. 2016 Nov 28. pii: AAC.01805.
    PubMed     Text format     Abstract available

  8. ZENG W, Bai Y, Wang M, Wang Z, et al
    Significant Divergence in Sensitivity to Antimalarial Drugs between Neighboring Plasmodium falciparum Populations along the Eastern Border of Myanmar.
    Antimicrob Agents Chemother. 2016 Dec 5. pii: AAC.01689.
    PubMed     Text format     Abstract available

  9. AGEEVETS V, Sopova J, Lazareva I, Malakhova M, et al
    Genetic Environment of the blaKPC-2 Gene in a Klebsiella pneumoniae Isolate That May Have Been Imported to Russia from Southeast Asia.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  10. SADER HS, Castanheira M, Flamm RK
    Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  11. CAHILL ST, Cain R, Wang DY, Lohans CT, et al
    Cyclic Boronates Inhibit All Classes of beta-Lactamases.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  12. HACHEM R, Reitzel R, Rolston K, Chaftari AM, et al
    Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available

  13. AJILEYE A, Alvarez N, Merker M, Walker TM, et al
    Some synonymous and non-synonymous gyrA mutations in Mycobacterium tuberculosis lead to systematic false-resistance results to fluoroquinolones with the Hain GenoType MTBDRsl assays.
    Antimicrob Agents Chemother. 2017 Jan 30. pii: AAC.02169.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  14. KLEINE CE, Schlabe S, Hischebeth GTR, Molitor E, et al
    Successful therapy of a multi-resistant EBSL (SHV-12)-producing and fluoroquinolone-resistant Salmonella enterica subsp. enterica serovar Typhi infection using combination therapy of meropenem and fosfomycin.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. TASHIRO M, Fushimi K, Kawano K, Takazono T, et al
    Comparison of efficacy of antimicrobial agents among hospitalized patients with Mycoplasma pneumoniae pneumonia in Japan during large epidemics of macrolide-resistant M. pneumoniae infections: A nationwide observational study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. FABRE V, Cosgrove SE
    A Coordinated and Sustained Response to the Threat of Antibiotic Resistance Is Critical: Lessons Learned From Israel.
    Clin Infect Dis. 2017 Jul 18. doi: 10.1093.
    PubMed     Text format    

  17. GEISSLER AL, Bustos Carrillo F, Swanson K, Patrick ME, et al
    Increasing Campylobacter Infections, Outbreaks, and Antimicrobial Resistance in the United States, 2004-2012.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. MACESIC N, Nelson B, Uhlemann AC
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: De Novo or Drug Exposure?
    Clin Infect Dis. 2017;65:702-703.
    PubMed     Text format    

  19. FARHAT MR, Jacobson KR, Franke MF, Kaur D, et al
    Fluoroquinolone Resistance Mutation Detection Is Equivalent to Culture-Based Drug Sensitivity Testing for Predicting Multidrug-Resistant Tuberculosis Treatment Outcome: A Retrospective Cohort Study.
    Clin Infect Dis. 2017;65:1364-1370.
    PubMed     Text format     Abstract available

  20. ARDAL C, Rottingen JA, Opalska A, Van Hengel AJ, et al
    Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Clin Infect Dis. 2017;65:1378-1382.
    PubMed     Text format     Abstract available

  21. SCHECHTER MC, Bizune D, Kagei M, Machaidze M, et al
    Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
    Clin Infect Dis. 2017 Aug 3. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. MILES-JAY A, Weissman SJ, Adler AL, Tchesnokova V, et al
    Epidemiology and antimicrobial resistance characteristics of the ST131-H30 subclone among extraintestinal Escherichia coli collected from US children.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. KLEIN EY, Mojica N, Jiang W, Cosgrove SE, et al
    Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. AVERBUCH D, Tridello G, Hoek J, Mikulska M, et al
    Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant patients: intercontinental prospective study of Infectious Diseases Working Party of the European Bone Marrow Transplantation group.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. GURIEVA T, Dautzenberg MJD, Gniadkowski M, Derde LPG, et al
    The transmissibility of antibiotic-resistant Enterobacteriaceae in Intensive Care Units.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. KNIGHT GM, Costelloe C, Murray KA, Robotham JV, et al
    Addressing the unknowns of antimicrobial resistance: quantifying and mapping the drivers of burden.
    Clin Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. SCHWABER MJ, Carmeli Y
    The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. LEUNG V, Vincent C, Edens T, Miller M, et al
    Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection.
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Antimicrob Chemother

  30. BRIAND C, Dollfus C, Faye A, Kantor E, et al
    Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
    J Antimicrob Chemother. 2017;72:837-843.
    PubMed     Text format     Abstract available

  31. DUGGETT NA, Sayers E, AbuOun M, Ellis RJ, et al
    Occurrence and characterization of mcr-1-harbouring Escherichia coli isolated from pigs in Great Britain from 2013 to 2015.
    J Antimicrob Chemother. 2017;72:691-695.
    PubMed     Text format     Abstract available

  32. KLETENKOV K, Hoffmann D, Boni J, Yerly S, et al
    Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?
    J Antimicrob Chemother. 2017;72:866-875.
    PubMed     Text format     Abstract available

  33. CAVACO LM, Bernal JF, Zankari E, Leon M, et al
    Detection of linezolid resistance due to the optrA gene in Enterococcus faecalis from poultry meat from the American continent (Colombia).
    J Antimicrob Chemother. 2016 Dec 20. pii: dkw490. doi: 10.1093.
    PubMed     Text format     Abstract available

  34. SULLY EK, Geller BL, Li L, Moody CM, et al
    Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
    J Antimicrob Chemother. 2017;72:782-790.
    PubMed     Text format     Abstract available

  35. STEFIC K, Salmona M, Capitao M, Splittgerber M, et al
    Unravelling the dynamics of selection of multiresistant variants to integrase inhibitors in an HIV-1-infected child using ultra-deep sequencing.
    J Antimicrob Chemother. 2017;72:850-854.
    PubMed     Text format     Abstract available


    J Med Microbiol

  36. MANSFIELD JM, Herrmann P, Jesionowski AM, Vickerman MM, et al
    Streptococcus gordonii pheromone s.g.cAM373 may influence the reservoir of antibiotic resistance determinants of Enterococcus faecalis origin in the oral metagenome.
    J Med Microbiol. 2017 Oct 12. doi: 10.1099/jmm.0.000613.
    PubMed     Text format     Abstract available


    JAMA

  37. KAHN PA, Gardin TM
    H-1B Visa Applications for Physicians-Reply.
    JAMA. 2017;318:1188.
    PubMed     Text format    

  38. IROEGBU N, Jachtorowycz M, Sherman M
    H-1B Visa Applications for Physicians.
    JAMA. 2017;318:1187-1188.
    PubMed     Text format    


    PLoS Biol

  39. KRASOVEC R, Richards H, Gifford DR, Hatcher C, et al
    Spontaneous mutation rate is a plastic trait associated with population density across domains of life.
    PLoS Biol. 2017;15:e2002731.
    PubMed     Text format     Abstract available


    PLoS One

  40. PHUMISANTIPHONG U, Siripanichgon K, Reamtong O, Diraphat P, et al
    A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci.
    PLoS One. 2017;12:e0186415.
    PubMed     Text format     Abstract available

  41. AKPAKA PE, Kissoon S, Jayaratne P, Wilson C, et al
    Genetic characteristics and molecular epidemiology of vancomycin-resistant Enterococci isolates from Caribbean countries.
    PLoS One. 2017;12:e0185920.
    PubMed     Text format     Abstract available

  42. THUY DB, Campbell J, Hoang NVM, Trinh TTT, et al
    A one-year prospective study of colonization with antimicrobial-resistant organisms on admission to a Vietnamese intensive care unit.
    PLoS One. 2017;12:e0184847.
    PubMed     Text format     Abstract available

  43. ROSALES-REYES R, Gayosso-Vazquez C, Fernandez-Vazquez JL, Jarillo-Quijada MD, et al
    Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
    PLoS One. 2017;12:e0182899.
    PubMed     Text format     Abstract available

  44. ILMJARV T, Naanuri E, Kivisaar M
    Contribution of increased mutagenesis to the evolution of pollutants-degrading indigenous bacteria.
    PLoS One. 2017;12:e0182484.
    PubMed     Text format     Abstract available

  45. CHAMBAL LM, Samo Gudo E, Carimo A, Corte Real R, et al
    HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    PLoS One. 2017;12:e0181836.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: